Glutamatergic Animal Models of Schizophrenia

E-ISSN： 1873-4286|18|12|1593-1604

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.12, 2012-04, pp. : 1593-1604

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

From Rodents to Recovery: Development of Animal Models of Schizophrenia

By Higgins G.A.

CNS Drugs, Vol. 9, Iss. 1, 1998-01 ,pp. : 59-68

Adis International

Access to resources Recommend Favorite

Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia

By Castner Stacy Goldman-Rakic Patricia Williams Graham

Psychopharmacology, Vol. 174, Iss. 1, 2004-06 ,pp. : 111-125

Springer Publishing Company

Access to resources Recommend Favorite

Glutamatergic neurotransmission modulators as emerging new drugs for schizophrenia

By Heresco-Levy Uriel

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 827-844

Informa Healthcare

Access to resources Recommend Favorite

The Integration of the Glutamatergic and the White Matter Hypotheses of Schizophrenia's Etiology

Current Neuropharmacology, Vol. 10, Iss. 1, 2012-03 ,pp. : 2-11

Bentham Science Publishers

Access to resources Recommend Favorite

Allosteric Modulators for the Treatment of Schizophrenia: Targeting Glutamatergic Networks

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 1, 2013-01 ,pp. : 26-54

Bentham Science Publishers

Access to resources Recommend Favorite